Gilead Sciences Inc.
Current price124.3USD
Fair value (est., median)89.26USD
UndervaluedFair valueOvervalued
+39.3% above fair valueWould need to fall ~28.2% to reach fair value.
Health Check
52.7
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Value10.7/100
Trades about 39.3% above its estimated fair value.
- Discount to fair value
- -39.3%
- Price to book
- 6.8×
- Fair-value confidence
- —
Future49.6/100
Modest growth of about 8% a year is expected.
- Forecast growth (rev.)
- 8%
- Revenue CAGR (18y)
- 11.4%
- Earnings CAGR (18y)
- 9.8%
Past83.1/100
High-quality returns — ROE around 37.5%.
- Return on equity
- 37.5%
- Net margin
- 28.9%
- Earnings CAGR (18y)
- 9.8%
- Profitable years
- 19/19
Health56.3/100
Balance sheet is manageable.
- Debt to equity
- 109.8%
- Net debt to equity
- 76.5%
- Cash covers total debt
- No
- Free cash flow
- Positive
Dividend64/100
Yields 2.59%, paying out 47% of earnings.
- Dividend yield
- 2.59%
- Payout ratio
- 47%
- Covered by free cash flow
- Yes
- Years paying
- 11
- Dividend growth
- —
Rewards
- Attractive, covered dividend (2.59%).
Risks
- Trades 39.3% above estimated fair value.
- Expensive on book (P/B 6.8×).
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 27.30B | 27.28B | 27.12B | 28.75B | 29.44B |
| Net Income | 6.22B | 4.59B | 5.67B | 480.00M | 8.51B |
| Net Margin | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% |
| Operating Cash Flow | 11.38B | 9.07B | 8.01B | 10.83B | 10.02B |
| OCF Margin | 41.7% | 33.3% | 29.5% | 37.7% | 34.0% |
| Capital Expenditure | 579.00M | 728.00M | 585.00M | 523.00M | 563.00M |
| Free Cash Flow | 10.80B | 8.34B | 7.42B | 10.30B | 9.46B |
| FCF Margin | 39.6% | 30.6% | 27.4% | 35.8% | 32.1% |
| FCF Conversion | 173.6% | 181.7% | 131.0% | 2,146.9% | 111.1% |
| EPS (Diluted) | 5.01/sh | 3.70/sh | 4.56/sh | 0.39/sh | 6.85/sh |
| Dividend / Share | 2.90/sh | 2.99/sh | 3.07/sh | 3.16/sh | 3.22/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.59%
Dividend / share3.22 USD
If you invest
USD
Shares (≈)80
Est. annual income257.93 USD
At this rate, dividends alone return your capital in ~38.6 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | 0.82 | — | — | — | 0.82 | 0.6% |
| 2025 | 0.79 | 0.79 | 0.79 | 0.79 | 3.22 | 2.9% |
| 2024 | 0.77 | 0.77 | 0.77 | 0.77 | 3.16 | 4.1% |
| 2023 | 0.75 | 0.75 | 0.75 | 0.75 | 3.07 | 3.9% |
| 2022 | 0.73 | 0.73 | 0.73 | 0.73 | 2.99 | 4.4% |
| 2021 | 0.71 | 0.71 | 0.71 | 0.71 | 2.90 | 4.3% |
| 2020 | 0.68 | 0.68 | 0.68 | 0.68 | 2.78 | 4.1% |
| 2019 | 0.63 | 0.63 | 0.63 | 0.63 | 2.60 | 4.0% |
| 2018 | 0.57 | 0.57 | 0.57 | 0.57 | 2.39 | 3.3% |
| 2017 | 0.52 | 0.52 | 0.52 | 0.52 | 2.20 | 3.0% |
| 2016 | 0.43 | 0.47 | 0.47 | 0.47 | 1.98 | 2.4% |
| 2015 | — | — | — | — | 1.51 | 1.4% |
| 2014 | — | — | — | — | — | — |
| 2013 | — | — | — | — | — | — |
| 2012 | — | — | — | — | — | — |
| 2011 | — | — | — | — | — | — |
| 2010 | — | — | — | — | — | — |
| 2009 | — | — | — | — | — | — |
| 2008 | — | — | — | — | — | — |
| 2007 | — | — | — | — | — | — |
Corporate actions
DCash Dividend
0.82 USD /sh2026-03-13
DCash Dividend
0.79 USD /sh2025-12-15
DCash Dividend
0.79 USD /sh2025-09-15
DCash Dividend
0.79 USD /sh2025-06-13
DCash Dividend
0.79 USD /sh2025-03-14
DCash Dividend
0.77 USD /sh2024-12-13
DCash Dividend
0.77 USD /sh2024-09-13
DCash Dividend
0.77 USD /sh2024-06-14
DCash Dividend
0.77 USD /sh2024-03-14
DCash Dividend
0.75 USD /sh2023-12-14
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham).
Discounted Cash Flow
Tap to adjust assumptions
397.39 USD
Dividend Discount Model
Tap to adjust assumptions
89.26 USD
Graham Number
Tap to adjust assumptions
48.90 USD
Residual Income (justified P/B)
Excluded — needs positive book value
N/A
Earnings Power Value
Excluded — non-positive normalized earnings
N/A
Fair Value (median)89.26 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 6.72%
- CAPM cost of equity
- 6.98%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Gilead Sciences Inc. regularly?
Starting year
- Invested
- 1K/yr · 35K total(1992 → today · 35 yrs)
- your value today is
- 2.2M USD
- Total return
- +6203.7%(+1173.4% Dividends · +5030.4% Capital gain)
- Annualised (IRR)
- +19.7%
Invested35KUSD
Dividends410.7KUSD
Capital gain1.8MUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.